Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sheng Xue Wan
- Development stage
- Unknown
- Lead developer
- Jilin Huakang Pharmaceutical
- Modality
- Peptides, Small Molecules
- Administration
- Oral
01
Overview
Sheng Xue Wan is a Traditional Chinese Medicine (TCM) formulation primarily indicated for the treatment of various blood-related deficiencies, including anemia, leukopenia, and thrombocytopenia. It is frequently utilized as an adjuvant therapy to mitigate bone marrow suppression (myelosuppression) induced by chemotherapy or radiotherapy in cancer patients. The formulation typically consists of a complex mixture of herbal and animal-derived ingredients, including *Cervus elaphus* (deer antler), *Panax ginseng*, *Astragalus membranaceus*, and *Angelica sinensis*. These components are believed to work synergistically to tonify Qi and nourish blood, specifically by stimulating the proliferation and differentiation of hematopoietic stem cells in the bone marrow. By enhancing the production of red blood cells, white blood cells, and platelets, Sheng Xue Wan helps restore hematological parameters and improve the overall immune status and quality of life for patients with chronic hematopoietic disorders.
- Brand names
- Sheng Xue Wan
- Other names
- Shengxue WanBlood-Generating Pills
02
Targets
STAT3 (Signal Transducer and Activator of Transcription 3)KIT (c-KIT proto-oncogene receptor tyrosine kinase)PIK3R1 (Phosphoinositide-3-kinase regulatory subunit 1)GRB2 (Growth factor receptor-bound protein 2)
Beyond the preview
Go deeper on Sheng Xue Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sheng Xue Wan.